LeMaitre Vascular (NASDAQ:LMAT) is a specialty medical device company focused on the development, manufacture and marketing of products for the treatment of peripheral vascular disease. Headquartered in Burlington, Massachusetts, the company’s offerings include a broad portfolio of vascular surgical instruments, grafts, patches, catheters and embolic protection devices. LeMaitre’s product lines address key areas such as arterial reconstruction, endovascular repair and vascular access, serving the needs of cardiovascular surgeons and interventional specialists.
Founded in 1983 by George D. LeMaitre, a vascular surgeon who sought to improve patient outcomes through innovation, the company has introduced numerous technologies that have become standards in surgical practice. Early success with devices such as the LeMaitre valvulotome laid the groundwork for ongoing expansion into complementary product categories. Over the decades, the company has grown both organically and through targeted acquisitions, continuously enhancing its ability to deliver comprehensive solutions for blood flow restoration.
LeMaitre Vascular sells its products worldwide, with direct sales and distribution partnerships spanning North America, Europe, Asia-Pacific and Latin America. Its international footprint allows it to collaborate with hospitals, surgical centers and healthcare systems around the globe, adapting its technology portfolio to meet regional regulatory requirements and clinical preferences. By maintaining a network of field-based clinical specialists and customer support teams, the company ensures that its innovations are effectively integrated into surgical workflows.
Committed to ongoing research and development, LeMaitre Vascular invests in advancing technologies that address unmet clinical needs in vascular surgery. The company’s leadership team brings together expertise in medical device engineering, regulatory affairs and commercial strategy, guiding efforts to expand into new markets and therapeutic areas. Through its focus on quality, innovation and customer partnership, LeMaitre Vascular aims to improve long-term patient outcomes in the treatment of peripheral vascular disease.
